Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma.
作者信息
Bhamidipati Castigliano M, Ailawadi Gorav, Bergin James, Kern John A
机构信息
Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
出版信息
J Thorac Cardiovasc Surg. 2010 Jul;140(1):e7-8. doi: 10.1016/j.jtcvs.2009.09.046. Epub 2009 Nov 27.
Abstract
摘要
相似文献
1
Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma.
J Thorac Cardiovasc Surg. 2010 Jul;140(1):e7-8. doi: 10.1016/j.jtcvs.2009.09.046. Epub 2009 Nov 27.
2
Early stenosis of an aortic porcine bioprosthesis due to thrombosis: Case report and literature review.
J Thorac Cardiovasc Surg. 2015 Jun;149(6):e83-6. doi: 10.1016/j.jtcvs.2015.02.039. Epub 2015 Feb 26.
3
Thrombotic occlusion of an aortic-root xenograft during left ventricular assistance.
Tex Heart Inst J. 2011;38(1):66-7.
4
Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
Circ Heart Fail. 2016 May;9(5). doi: 10.1161/CIRCHEARTFAILURE.115.002896.
5
Bailout surgical explantation of a transcatheter valve-in-valve for subacute thrombosis: When there is no time for anticoagulation: Case report and literature review.
Cardiovasc Revasc Med. 2018 Jul;19(5 Pt A):536-539. doi: 10.1016/j.carrev.2017.12.005. Epub 2017 Dec 13.
6
Complete LVOT obstruction following aortic valve replacement after HeartMate II implantation.
J Card Surg. 2014 May;29(3):432. doi: 10.1111/jocs.12249. Epub 2013 Dec 4.
7
Acute bioprosthetic thrombosis immediately after aortic valve replacement.
J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):167-9. doi: 10.2459/JCM.0b013e32831a9a98.
8
Explantation of a 44-year-old Starr-Edwards mitral valve for delayed hemolysis.
J Thorac Cardiovasc Surg. 2010 Sep;140(3):e35-6. doi: 10.1016/j.jtcvs.2009.11.011. Epub 2010 Feb 1.
9
Hemolysis from aortic regurgitation mimicking pump thrombosis in a patient with a HeartMate II left ventricular assist device: a case report.
ASAIO J. 2012 May-Jun;58(3):278-80. doi: 10.1097/MAT.0b013e31824708a8.
10
Aortic bioprosthesis--avoid obstructive properties due to thrombosis as altered durability due to structural valve deterioration.
J Thorac Cardiovasc Surg. 2010 May;139(5):1354. doi: 10.1016/j.jtcvs.2009.12.044.
引用本文的文献
1
Special Considerations for Advanced Heart Failure Surgeries: Durable Left Ventricular Devices and Heart Transplantation.
J Cardiovasc Dev Dis. 2024 Apr 15;11(4):119. doi: 10.3390/jcdd11040119.
2
Influence of shear rate and surface chemistry on thrombus formation in micro-crevice.
J Biomech. 2021 May 24;121:110397. doi: 10.1016/j.jbiomech.2021.110397. Epub 2021 Mar 26.
3
Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps.
Int J Artif Organs. 2020 Oct;43(10):653-662. doi: 10.1177/0391398820903734. Epub 2020 Feb 11.
4
Pre-implant left ventricular apex position predicts risk of HeartMate II pump thrombosis.
J Card Surg. 2017 Dec;32(12):837-842. doi: 10.1111/jocs.13382. Epub 2017 Dec 10.
5
New methodologies to accurately assess circulating active transforming growth factor-β1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices.
Transl Res. 2018 Feb;192:15-29. doi: 10.1016/j.trsl.2017.10.006. Epub 2017 Nov 5.
6
High-speed visualization of disturbed pathlines in axial flow ventricular assist device under pulsatile conditions.
J Thorac Cardiovasc Surg. 2015 Oct;150(4):938-44. doi: 10.1016/j.jtcvs.2015.06.049. Epub 2015 Jun 30.
7
Resolution of hemolysis from pump thrombus during left ventricular assist device exchange.
World J Clin Cases. 2014 Aug 16;2(8):373-6. doi: 10.12998/wjcc.v2.i8.373.
8
Dysphagia in the setting of left ventricular assist device hemolysis.
ASAIO J. 2013 May-Jun;59(3):322-3. doi: 10.1097/MAT.0b013e31828bbb00.
本文引用的文献
1
Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).
J Am Coll Cardiol. 2009 Jun 9;53(23):2162-7. doi: 10.1016/j.jacc.2009.02.048.
2
Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
J Thorac Cardiovasc Surg. 2008 Nov;136(5):1318-23. doi: 10.1016/j.jtcvs.2007.12.077. Epub 2008 Sep 14.
3
Association of device surface and biomaterials with immunologic sensitization after mechanical support.
J Thorac Cardiovasc Surg. 2008 Jun;135(6):1372-9. doi: 10.1016/j.jtcvs.2007.11.049.
4
Thrombus formation in a HeartMate II left ventricular assist device.
J Thorac Cardiovasc Surg. 2008 Jan;135(1):203-4. doi: 10.1016/j.jtcvs.2007.08.048.
5
A successful anticoagulation protocol for the first HeartMate II implantation in the United States.
Tex Heart Inst J. 2005;32(3):399-401.
Zotero 插件